Clinical Trial Update: Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial compares nab-paclitaxel plus carboplatin versus nab-paclitaxel plus capecitabine in advanced triple-negative breast cancer and is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Capecitabine (Xeloda) (Capecitabine)
• Nab-paclitaxel (Abraxane) (nab-paclitaxel)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Triple Negative Breast Cancer, Nab-paclitaxel | Phase 2 | Status: RECRUITING